Substituted pyrazoles as novel sEH antagonist: Investigation of key binding interactions within the catalytic domain (Q27664956)

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

30 July 2024

7

John R. Proudfoot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934334

30 July 2024

author name string

Ho Yin Lo

1

0 references

Alison Kukulka

6

0 references

Raj Betageri

8

0 references

Tom Kirrane

9

0 references

Usha Patel

10

0 references

Rajiv Sharma

11

0 references

Mary Ann Hoermann

12

0 references

Alisa Kabcenell

13

0 references

Stéphane De Lombaert

14

0 references

Chuk C. Man

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934334

30 July 2024

Roman W. Fleck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934334

30 July 2024

Neil A. Farrow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934334

30 July 2024

Richard H. Ingraham

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934334

30 July 2024

language of work or name

English

0 references

publication date

15 November 2010

0 references

19 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934334

full work available at URL

30 July 2024

https://api.elsevier.com/content/article/PII:S0960894X10014046?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

https://api.elsevier.com/content/article/PII:S0960894X10014046?httpAccept=text/plain

30 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Bioorganic & Medicinal Chemistry Letters

30 July 2024

published in

0 references

volume

20

0 references

issue

22

0 references

page(s)

6379-83

0 references

cites work

P-450 metabolites of arachidonic acid in the control of cardiovascular function

1

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Epoxygenase pathways of arachidonic acid metabolism

30 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels

30 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels.

30 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase

30 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

30 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

American Journal of Physiology

30 July 2024

7

279

R455

Kozak

2000

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

30 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Purification of human liver cytosolic epoxide hydrolase and comparison to the microsomal enzyme

30 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Cloning and characterization of mouse 5′-AMP-activated protein kinase γ3 subunit

30 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Theoretical Study of the Full Reaction Mechanism of Human Soluble Epoxide Hydrolase

30 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

American Journal of Physiology

30 July 2024

13

277

H2098

Weintraub

1999

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

30 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases

30 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension

30 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase

30 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase

30 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase

30 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method

30 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase

30 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.

30 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Non-urea functionality as the primary pharmacophore in soluble epoxide hydrolase inhibitors

30 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities

30 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Orally bioavailable potent soluble epoxide hydrolase inhibitors

30 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility

30 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement

30 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors

30 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors

30 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors

30 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Journal of Pharmacology and Experimental Therapeutics

30 July 2024

31

187

211

Mitchell

1973

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

30 July 2024

32

35

844

Lin

1975

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Effects of the nitro-group on the mutagenicity and toxicity of some benzamines

30 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Nitrotyrosine formation in splenic toxicity of aniline

30 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Cytokine gene expression and activation of NF-kappa B in aniline-induced splenic toxicity

30 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Haloaniline-induced in vitro nephrotoxicity: effects of 4-haloanilines and 3,5-dihaloanilines

30 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Analytical and biological analysis of test materials from the synthetic fuel technologies.

30 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Comutagenic effect of norharman with aminopyridine derivatives.

30 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Ultimate carcinogenic metabolites from aromatic and heterocyclic aromatic amines: a computational study in relation to their mutagenic potency.

30 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

The preparation and some reactions of a benzotriazole substituted vinamidinium salt

30 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

Improved radiolabeled substrates for soluble epoxide hydrolase

30 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BMCL.2010.09.095

30 July 2024

Identifiers

0 references